We are live on
!
Find out more
TAF
Tredje AP-fonden Portfolio holdings
AUM
$22.1B
1-Year Est. Return
41.68%
This Fund
S&P 500
This Quarter
Est. Return
-6.33%
1 Year Est. Return
+41.68%
3 Year Est. Return
+127.87%
5 Year Est. Return
+164.02%
10 Year Est. Return
+659.26%
AUM
$1.02B
AUM Growth
-$225M
(-18%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-10.6%
Top 10 Holdings %
Top 10 Hldgs %
23.28%
Holding
309
New
10
Increased
23
Reduced
263
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$25.4M |
| 2 |
Gilead Sciences
GILD
|
+$22.1M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$17.3M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$14.4M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$31.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$13.9M |
| 3 |
Merck
MRK
|
+$11.1M |
| 4 |
Walt Disney
DIS
|
+$7.99M |
| 5 |
CELG
Celgene Corp
CELG
|
+$6.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.44% |
| 2 | Financials | 14.75% |
| 3 | Technology | 13.83% |
| 4 | Communication Services | 10.78% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Merck
MRK
$320B
| $9.21M | 0.9% |
193,401
-209,783
| -52% | -$11.1M |
|
27
AT&T
T
$162B
| $9M | 0.88% |
365,701
-4,140
| -1% | -$106K |
|
28
PepsiCo
PEP
$188B
| $8.96M | 0.87% |
94,243
-10,333
| -10% | -$983K |
|
29
Visa
V
$675B
| $8.8M | 0.86% |
126,352
-10,528
| -8% | -$752K |
|
30
Cisco
CSCO
$488B
| $8.57M | 0.84% |
326,626
-226,785
| -41% | -$6.12M |
|
31
Philip Morris
PM
$292B
| $8.04M | 0.79% |
100,106
-8,086
| -7% | -$665K |
|
32
Oracle
ORCL
$431B
| $8.02M | 0.78% |
222,127
-24,486
| -10% | -$941K |
|
33
CVS Health
CVS
$122B
| $7.05M | 0.69% |
73,036
-7,935
| -10% | -$834K |
|
34
UnitedHealth
UNH
$372B
| $6.99M | 0.68% |
60,262
-6,651
| -10% | -$796K |
|
35
Altria Group
MO
$112B
| $6.94M | 0.68% |
126,196
-13,854
| -10% | -$743K |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| $6.89M | 0.67% |
25,343
-894
| -3% | -$275K |
|
37
Boeing
BA
$186B
| $6.79M | 0.66% |
51,846
-5,659
| -10% | -$785K |
|
38
HP
HPQ
$27.7B
| $6.74M | 0.66% |
575,422
-270,884
| -32% | -$3.52M |
|
39
Bristol-Myers Squibb
BMY
$132B
| $6.43M | 0.63% |
107,944
+106,936
| +10,609% | +$6.78M |
|
40
Northrop Grumman
NOC
$82.2B
| $5.99M | 0.58% |
36,066
-3,924
| -10% | -$658K |
|
41
McDonald's
MCD
$194B
| $5.97M | 0.58% |
60,581
-6,674
| -10% | -$650K |
|
42
Mastercard
MA
$494B
| $5.9M | 0.58% |
65,446
-7,117
| -10% | -$669K |
|
43
SLB Ltd
SLB
$77.1B
| $5.74M | 0.56% |
82,554
-9,041
| -10% | -$716K |
|
44
3M
MMM
$93.8B
| $5.71M | 0.56% |
48,171
-5,305
| -10% | -$652K |
|
45
Nike
NKE
$61.7B
| $5.49M | 0.54% |
89,006
-9,742
| -10% | -$551K |
|
46
Starbucks
SBUX
$120B
| $5.42M | 0.53% |
95,403
-10,489
| -10% | -$588K |
|
47
Eli Lilly
LLY
$1.08T
| $5.3M | 0.52% |
63,287
-6,933
| -10% | -$585K |
|
48
Booking.com
BKNG
$159B
| $4.98M | 0.49% |
100,650
+11,175
| +12% | +$555K |
|
49
Union Pacific
UNP
$174B
| $4.97M | 0.49% |
55,841
-6,092
| -10% | -$556K |
|
|
50
Johnson & Johnson
JNJ
$625B
| $4.96M | 0.48% |
53,180
-143,345
| -73% | -$13.9M |
|
Similar funds
AM
BA
DSA
IC
FAM
Tredje AP-fonden's Q3 2015 Portfolio in Review
As of Q3 2015, Tredje AP-fonden held 309 positions worth $1.02B, down 18% from $1.25B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Tredje AP-fonden withdrew a net $109M in Q3 2015, closing 11 positions and reducing 263 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $31.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Tredje AP-fonden opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $0.
- Tredje AP-fonden's largest Q3 2015 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 200,000 shares worth $0.
- Tredje AP-fonden added most to Pfizer in Q3 2015, an estimated $25.4M increase.
- Tredje AP-fonden's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $13.9M.
- Tredje AP-fonden fully exited iShares MSCI Emerging Markets ETF in Q3 2015, selling an estimated $31.9M.
- Tredje AP-fonden's ten largest holdings make up 23% of its $1.02B portfolio in Q3 2015.
- Tredje AP-fonden opened 10 new positions and closed 11 in Q3 2015.
- Tredje AP-fonden's portfolio value fell 18% quarter-over-quarter to $1.02B.
Based on Tredje AP-fonden's 13F filing for Q3 2015, filed 10 Nov 2015.